Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Adm Policy Ment Health. 2017 Sep;44(5):735–746. doi: 10.1007/s10488-016-0746-1

Table 3.

Percent of Patients Receiving Each of 14 Treatments at any Point Following Intake

Treatment Percent of Patients Receiving Each Treatment (N = 193)
1. Aripiprazole 18.1
2. Olanzapine 1.0
3. Quetiapine 10.4
4. Mirtazapine 8.8
5. Fluoxetine 8.8
6. Paroxetine 3.1
7. Citalopram 23.3
8. Escitalopram 6.7
9. Sertraline 12.4
10. Duloxetine 3.6
11. Venlafaxine 5.2
12. Desvenlafaxine 1.6
13. Bupropion 10.9
14. Psychotherapy 75.1

Note. Data is shown for the N = 193 patients who enrolled in the predictive validity study and attended at least one treatment session. Some patients received multiple treatments in succession and/or simultaneously.